PARTICIPATE IN FORTITUDE-ALS

FORTITUDE-ALS is a clinical trial of an investigational oral drug for the treatment of amyotrophic lateral sclerosis (ALS). This clinical trial is now enrolling participants in both the United States and Canada. 

WHO: Adults diagnosed with ALS within the last 24 months

WHERE: Locations in the United States and Canada

TRAVEL EXPENSES: Qualified participants may receive travel reimbursement

PLEASE COMPLETE THIS FORM TO BE CONSIDERED FOR PARTICIPATION: